Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-673-7 | CAS number: 132638-45-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- An assessment of toxicokinetics, based on available data, in accordance with Annex VIII, Section 8.8.1 of Regulation (EC) No 1907/2006 (REACH)
- Type of information:
- other: Desk-based assessment
- Adequacy of study:
- key study
- Study period:
- Not applicable
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
- Objective of study:
- toxicokinetics
- Principles of method if other than guideline:
- An assessment of toxicokinetics, based on available data, in accordance with Annex VIII, Section 8.8.1 of Regulation (EC) No 1907/2006 (REACH)
- GLP compliance:
- no
Test material
- Reference substance name:
- 2-methoxy-4-methylphenyl methyl carbonate
- EC Number:
- 700-673-7
- Cas Number:
- 132638-45-0
- Molecular formula:
- C10H12O4
- IUPAC Name:
- 2-methoxy-4-methylphenyl methyl carbonate
- Test material form:
- solid
- Details on test material:
- Detailed information on the 'test material identity' is provided in the attached document including information on individual constituents.
Constituent 1
Test animals
- Details on species / strain selection:
- No animals were used in this desk-based assessment.
- Details on test animals or test system and environmental conditions:
- Not applicable
Administration / exposure
- Details on exposure:
- No animals were used in this desk-based assessment.
- Duration and frequency of treatment / exposure:
- Desk-based assessment.
- No. of animals per sex per dose / concentration:
- No animals were used in this desk-based assessment.
- Positive control reference chemical:
- Desk-based assessment.
- Details on study design:
- Not applicable
- Details on dosing and sampling:
- Not applicable
- Statistics:
- Not applicable
Results and discussion
- Preliminary studies:
- Not applicable
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- The molecular weight of the substance constituents is low i.e. < 200 g/mol. The n-octanol/water partition coefficient is relatively low (log Pow = 2.27), with a water solubility of 376 mg/L and vapour pressure 0.1 Pa. This is suggestive of favourable absorption from the GI tract following oral administration. Oral absorption of the substance is mainly via passive diffusion to into portal circulation with delivery into the liver i.e. first pass metabolism and relative high pulmonary uptake. This is supported by the systemic availability repeated dose toxicity studies. Although these physicochemical properties indicate the substance will demonstrate moderate dermal absorption, the substance is not expected to be surface active which mean transfer between the stratum corneum and the epidermis is restricted, thus overall uptake via the dermal route is limited. This is demonstrated by the lack of significant systemic and local toxicity following dermal exposure studies. Based on the vapour pressure of the test item and being crystalline solid, volatility is expected to be very low therefore systemic availability via the inhalable route is expected to be very low. This is supported by tolerability of the test item in rats following acute exposure.
- Details on distribution in tissues:
- The substance possesses physico-chemical properties which indicate test item can easily pass through aqueous pores or be carried through the epithelial barrier by the bulk passage of water into the liver. This will limit distribution of the parent compound systemically and limited half-life of the parent compound in blood plasma. A wide distribution of the substance via inhalation is expected as it can easily be taken up into circulatory system, however, being of low volatility availability of the test item via the inhalation route is limited.
- Details on excretion:
- Parameters in liver, lung and thyroid demonstrate possible hepatic metabolism and renal elimination. The n-Octanol/water partition coefficient (log Pow = 2.27) and the molecular weight of the substance is suggestive of low accumulation of the substance in fatty tissues after absorption from gastro-intestinal tract, the substance may enter circulation via lymphatic system. Based on the molecular structure and solubility, excretion into urine as conjugated metabolites is assumed to be a preferred route of elimination. A small percentage of the parent compound may also be excreted via bile and faces.
Metabolite characterisation studies
- Metabolites identified:
- not measured
- Details on metabolites:
- Metabolism of the substance is expected to be mainly through the liver and to a small extent via GI tract phase I and II enzymes with principal alcohol metabolizing enzymes being alcohol dehydrogenase [ADH] and aldehyde dehydrogenase [ALDH2]. Hydrolysis of the carbonate esters (R1OCOOR2) would result in the production of metabolites containing alcohol (R1OH, R2OH) and acidic (containing HO2/CO2) derivatives. The acidic and alcohols derivatives will be further conjugated with glucuronides and sulphate via glucuronsyl transferase and sulphotransferase with subsequent elimination via urine. This is demonstrated by centrilobular hepatocyte hypertrophy in the liver in male rats9, 10. This is considered as an adaptation reaction following exposure to xenobiotic(s).
Applicant's summary and conclusion
- Conclusions:
- The substance possesses physico-chemical properties which are favourable for ADME. Exposure from oral and inhalation routes are most favourable and therefore the substance is expected to be widely distributed especially via inhalation exposure. Based on the log Pow of < 3 and BCF < 2,000, bioaccumulation is not significant and elimination is expected to be rapid. The lack of systemic and local toxicity observed following in vivo skin irritation and sensitisation studies shows that systemic bioavailability of this substance is limited via dermal exposure. The clinical signs observed following oral sub-acute exposure support oral absorption of teste item and clinical signs reported in organs such as the liver is demonstrative of distribution, biotransformation and elimination of the test item. It can be concluded that the basic toxicokinetics of the test item does not pose significant toxicological concern through evaluation of the available data.
- Executive summary:
A desk-based assessment of the basic toxicokinetics of the substance, in accordance with Regulation (EC) 1907/2006: Annex VIII - Section 8.8.1. The substance possesses physico-chemical properties which are favourable for ADME. Exposure from oral and inhalation routes are most favourable and therefore the substance is expected to be widely distributed especially via inhalation exposure. Based on the log Pow of < 3 and BCF < 2,000, bioaccumulation is not significant and elimination is expected to be rapid. The lack of systemic and local toxicity observed following in vivo skin irritation and sensitisation studies shows that systemic bioavailability of this substance is limited via dermal exposure. The clinical signs observed following oral sub-acute exposure support oral absorption of teste item and clinical signs reported in organs such as the liver is demonstrative of distribution, biotransformation and elimination of the test item. It can be concluded that the basic toxicokinetics of the test item does not pose significant toxicological concern through evaluation of the available data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)